Nanobiotix Prices $98.6 Million Global Offering and Pre-Funded Warrants

On May 21, 2026, Nanobiotix S.A. announced the pricing of an oversubscribed global follow-on offering for aggregate gross proceeds of approximately $98.6 million (€85.0 million). The offering includes 225,373 American Depositary Shares (ADSs) in the United States priced at $38.98 per ADS, and an international offering of 1,959,289 ordinary shares and 345,099 pre-funded warrants (PFW) to qualified investors in Europe. The ordinary shares were priced at €33.60, representing a 14.92% discount to the three-day volume-weighted average price. Nanobiotix has also granted underwriters a 30-day option to purchase up to an additional 15% of the ADSs. The company intends to allocate the net proceeds as follows: less than 10% for the development of JNJ-1900 (NBTXR3), 50-60% to advance its Nanoprimer and other platforms, and 30-40% for general corporate purposes. The offering is expected to close on May 26, 2026. Management believes the proceeds, combined with current cash, will extend the company's financial runway into 2029. existing shareholders Invus, Qatar Holding LLC, and JJDC participated in the transaction.